Clonal hematopoiesis in patients with telomere biology disorders, genomic alterations in extracutaneous juvenile xanthogranulomas, and the BCMA-CD3 bispecific antibody teclistamab in relapsed/refractory multiple myeloma
Blood Podcast
00:00
Efficacy and Management of Extracutaneous Xanthogranulomas and Teclistimab in Multiple Myeloma
This chapter explores the management of childhood patients with extracutaneous xanthogranulomas, focusing on spontaneous regression rates and genotypes. It also examines the efficacy and safety of teclistimab for relapsed/refractory multiple myeloma, emphasizing the need for large-scale studies to optimize treatment strategies.
Transcript
Play full episode
